Thrombocytopenia Therapy
Findings in thrombocytopenia therapy reported from Ullevaal University
Published in Drug Week, August 10th, 2007
A new study, "Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy," is now available. According to recent research from Oslo, Norway, "Therapeutic or prophylactic use of platelet concentrates (PC) is essential for patients with thrombocytopenia due to intensive chemotherapy for various malignancies. PC quality has been improved after introduction of storage containers that are more oxygen permeable than the second-generation PC containers."
"Consequently, shelf life of PCs at our blood bank has been extended to 6.5 days after monitoring each PC for bacterial contamination. In this...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-08-10)
More Articles from Drug Week
- Adverse Drug Reactions
Adverse reactions of natural health products/drugs under-reported, study shows - Alcoholism
Phone Counseling Can Coax Reluctant Alcoholism Patients Into Treatment - Anemia
UB scientist discovers novel iron-copper alliance - Attention Deficit Hyperactivity Disorder
Improvement following ADHD treatment sustained in most children - Bladder Cancer
New algorithm matches any tumor cells to best possible anti-cancer treatments - Breast Cancer
Group therapy fails to improve breast cancer survival - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
